virus
filovirida
famili
mani
viru
famili
requir
acid
ph
success
infect
therefor
suscept
action
chloroquin
although
mechan
action
chloroquin
clearli
indic
might
inhibit
filovir
infect
sever
clinic
trial
attempt
use
chloroquin
treatment
acut
viral
infectionsinclud
dengu
influenza
bcaus
low
phdepend
virus
report
chloroquin
clinic
efficaci
result
demot
chloroquin
potenti
treatment
viru
famili
requir
low
ph
infect
present
review
aim
investig
whether
chloroquin
could
combat
present
ebola
viru
epidem
also
explor
main
reason
report
lack
efficaci
literatur
sourc
pubm
scopu
googl
scholar
refer
list
articl
textbook
field
virolog
volum
cytokin
handbook
pharmacolog
medicin
principl
practic
hydroxychloroquin
chloroquin
retinopathi
present
analysi
conclud
chloroquin
might
find
place
treatment
ebola
either
monotherapi
combin
therapi
ineffect
chloroquin
analogu
hydroxychloroquin
treat
infect
low
phdepend
virus
result
failur
attain
sustain
steadi
state
concentr
suffici
increas
keep
ph
acid
organel
approxim
neutral
level
success
treat
filovir
infectionsor
viral
infect
emerg
emerg
low
phdepend
virusesa
steadi
state
chloroquin
plasma
concentr
least
whole
blood
concentr
must
achiev
sustain
patient
viraemia
becom
undetect
concentr
howev
rule
efficaci
higher
steadi
state
concentrationsalthough
concentr
might
accompani
sever
advers
effect
toxic
feasibl
conclus
preced
text
recent
support
subsequ
studi
show
amodiaquin
deriv
cq
abl
protect
human
infect
ebola
death
filovirida
familycontain
ebola
marburg
virus
compris
envelop
virus
nonseg
negativesens
rna
genom
consist
seven
gene
form
structur
nonstructur
protein
filovirus
current
circul
zair
speci
ebola
viru
ebov
virul
mortal
rate
rang
peplom
ebov
speci
compos
trimer
heterodim
glycoprotein
heavili
glycosyl
nlink
olink
glycan
contain
abund
andor
link
sialic
acid
peplom
broad
tropism
varieti
host
cell
organ
result
abil
bind
either
specif
nonspecif
variou
cell
surfac
molecul
howev
despit
broad
tropism
infect
filovirus
greatli
depend
acid
ph
organel
intern
viru
therefor
characterist
exploit
therapeut
filoviru
bind
surfac
molecul
plasma
membran
suscept
cellssuch
tissu
macrophag
monocyt
dendrit
cell
endotheli
cell
hepatocyteslead
intern
virion
vesicl
traffic
endosom
pathway
success
infect
suscept
cell
viru
requir
endosom
acidif
cleavag
glycoprotein
segment
peplom
host
endosom
proteas
activ
acid
ph
without
acidif
cleavag
infect
abrog
therefor
therapeut
agent
target
endosom
acidif
henc
phdepend
proteas
could
benefici
combat
present
african
ebov
epidem
success
infect
induc
local
system
releas
vari
amount
cytokin
chemokin
reactiv
oxygen
speci
nitric
oxid
mediat
eventu
result
gener
cell
death
patient
immun
system
abl
control
infect
patient
recov
convalesc
prolong
recov
patient
shown
produc
infecti
viru
mani
month
symptom
disappear
howev
patient
immun
system
unabl
control
infect
cycl
infect
suscept
cell
organ
occur
lead
releas
mediat
mention
preced
text
consequ
massiv
cell
death
manifest
fatal
case
extens
cell
death
mani
organsinclud
liver
spleen
lymph
node
kidney
adren
glandsand
coagulopathi
reveal
dissemin
intravascular
coagul
haemorrhag
petechia
ecchymosi
congest
uncontrol
bleed
venipunctur
site
mode
infect
filovirus
associ
patholog
may
uncov
achil
heel
therapeut
weaponri
base
chloroquin
cq
therapeut
exploit
tropism
chloroquin
acid
organel
treatment
filovir
infect
chloroquin
weak
base
commonli
use
treatment
malaria
autoimmun
diseas
rheumatoid
arthriti
system
lupu
erythematosu
readili
absorb
administ
either
oral
parenter
rout
becom
highli
concentr
tissu
adren
gland
liver
spleen
kidney
tissu
suffer
extens
necrosi
fatal
filovir
infect
cell
tissu
cq
becom
concentr
acid
organel
endosom
lysosom
golgi
vesicl
therebi
increas
ph
lead
dysfunct
sever
enzym
eg
requir
proteolyt
process
posttransl
modif
protein
cq
also
inhibit
product
sever
immunolog
mediat
excess
releas
contribut
autoimmun
diseas
system
lupu
erythematosu
rheumatoid
arthriti
therefor
cq
properti
consid
treatment
filovir
infect
associ
patholog
cqincreas
ph
acid
organel
shown
inhibit
sever
virusesinclud
influenza
b
sar
coronaviru
hepat
viru
borna
diseas
viruswhich
requir
low
ph
entri
suggest
cq
could
also
inhibit
filovirus
entri
cytoplasm
suscept
cell
therebi
abrog
infect
sinc
depend
endosom
acidif
activ
sever
host
endosom
proteas
cq
might
also
inhibit
assembl
bud
filoviruseswhich
partli
requir
late
endosom
assembl
accordingli
dysfunct
enzym
eg
glycosyltransferas
caus
cq
hydroxychloroquin
hcq
direct
result
increas
ph
andor
structur
chang
golgi
apparatu
shown
inhibit
glycosyl
sar
coronaviru
also
therebi
lead
product
noninfecti
virion
viru
decreas
infect
mechan
invok
explain
decreas
viral
load
observ
patient
oral
administ
hcq
mgday
week
result
though
obtain
nonrel
virus
could
suggest
cq
given
correct
dosag
might
inhibit
glycosyl
ebov
peplom
pronounc
occur
sinc
gp
filovirus
protein
involv
initi
infect
cytotox
depend
express
inhibit
glycosyl
could
potenti
inhibit
ebov
tropism
broad
varieti
host
cell
organ
lead
product
noninfecti
decreas
infect
viru
seen
decreas
ebov
pathogen
impair
glycosyl
could
therefor
save
time
adapt
immun
respons
normal
fail
fatal
case
establish
deal
infect
therapeut
exploit
immunomodulatori
properti
chloroquin
treatment
filovir
infect
apart
therapeut
exploit
increas
ph
dysfunct
enzym
caus
cq
immunomodulatori
properti
drug
could
also
exploit
therapeut
treatment
filovir
infectionassoci
patholog
sever
studi
suggest
multipl
organ
failur
hypovolem
shock
seen
fatal
case
like
result
direct
infect
destruct
suscept
cell
endotheli
cell
effect
proinflammatori
cytokin
chemokin
mediat
releas
infect
activ
cell
monocyt
macrophag
one
cytokin
strongli
implic
patholog
abl
increas
permeabl
endotheli
cell
shown
experi
conduct
human
umbil
vein
also
ablein
human
inject
recombin
formto
induc
sustain
activ
blood
coagul
also
caus
tissu
injuri
shock
role
patholog
fatal
associ
filovir
infect
confirm
fact
intramuscular
administr
serum
day
postinfect
abl
reduc
circul
concentr
protect
infect
rodent
death
patient
recov
infect
zair
ebov
zebov
two
recent
outbreak
gabon
transient
increas
plasma
concentr
onset
infectionwhich
decreas
cours
infect
convers
fatal
case
display
increas
sustain
concentr
fatal
highli
increas
concentr
solubl
tumour
necrosi
factor
receptor
also
detect
taken
togeth
observ
clearli
show
therapeut
agent
like
cq
abl
prevent
activ
macrophag
also
inhibit
secret
variou
cell
clinic
relev
concentr
could
benefit
treatment
filovir
infect
anoth
cytokin
like
implic
ebola
pathogenesisespeci
massiv
apoptosi
lymphopenia
associ
fatal
case
ebov
infectionsi
report
abl
increas
cellular
sensit
apoptosi
upregul
express
fa
fa
ligand
fatal
case
ebov
infect
express
fa
fa
ligand
shown
upregul
anoth
mechan
mightat
least
partaccount
massiv
apoptosi
detect
filoviru
infect
induct
product
monocytesmacrophag
neopterin
deriv
report
neopterin
induc
apoptosi
rat
alveolar
cell
line
plasma
concentr
neopterin
significantli
progress
increas
throughout
diseas
cours
fatal
case
zebov
infectionsbut
survivor
therefor
product
neopterin
upon
stimul
might
also
contribut
massiv
apoptosi
seen
fatal
case
ebov
infect
thu
sinc
massiv
apoptosi
seen
fatal
case
ebovinfect
patient
associ
product
neopterin
therapeut
agent
like
cq
shown
clinic
relev
concentr
inhibit
product
neopterin
variou
cell
could
great
benefit
treatment
patient
infect
present
zebov
filovirus
although
mechan
action
cq
variou
vitro
studi
suggest
cq
may
exert
benefit
infect
virus
requir
acid
ph
infect
andor
heavili
glycosyl
evok
detriment
immun
activ
sever
clinic
trial
attempt
use
cq
hcq
prevent
treatment
sever
viral
infectionsinclud
influenza
b
dengu
viral
infectionshav
report
cq
hcq
either
undetectablemoder
clinic
efficaci
actual
detriment
tabl
possibl
hypothes
mix
disappoint
result
may
attribut
knowingand
thu
achievingth
therapeut
steadi
state
plasma
whole
blood
cq
concentr
necessari
exert
therapeut
effect
refer
succeed
text
order
cq
use
treatment
infect
virus
requir
acid
ph
infect
andor
heavili
glycosyl
depend
envelop
glycoprotein
infect
therapeut
steadi
state
plasma
whole
blood
concentr
must
achiev
sustain
patient
viraemia
becom
undetect
succeed
text
summar
evid
use
determin
necessari
therapeut
steadi
state
plasma
whole
blood
cq
concentr
firstli
sever
vitro
studi
shown
optim
uptak
cq
sever
cell
type
isol
differ
anim
rang
concentr
caus
less
uptak
secondli
whole
blood
cq
ec
consid
vivo
threshold
cq
toxic
sinc
level
associ
signific
cardiovascular
effect
patient
cq
poison
whilst
patient
concentr
shown
signific
cardiovascular
event
thirdli
clinic
trial
summar
tabl
trial
administ
highest
hcq
dose
durat
suffici
attain
steadi
state
mean
report
moder
improv
sever
patient
patient
one
highest
hcq
level
approxim
equival
vitro
cq
ec
shown
inhibit
replic
best
respons
hcq
patient
absolut
tcell
increas
cellsmm
plasma
level
rna
decreas
cpm
percentag
tcell
increas
also
signific
improv
mitogen
respons
although
hiv
depend
acid
organel
infect
less
glycosyl
comparison
ebov
hcq
steadi
state
concentr
nevertheless
abl
inhibit
hiv
replic
affect
glycosyl
fourthli
steadi
state
cqhcq
concentr
detect
plasma
whole
blood
respect
shown
vivo
vitro
inhibit
viral
replic
overproduct
immunolog
mediat
associ
patholog
mani
viral
infect
autoimmun
diseas
conclud
transient
steadi
state
whole
blood
concentr
cq
like
signific
cardiovascular
event
steadi
state
whole
blood
concentr
cqhcq
abl
inhibit
viral
replic
glycosyl
product
immunolog
mediat
associ
viral
infect
optim
uptak
cq
human
like
lie
within
rang
therefor
steadi
state
cq
concentr
could
safe
suffici
rais
maintain
acid
organel
ph
level
approxim
neutral
therebi
inhibit
viral
replic
mechan
inhibit
endosom
proteas
inhibit
fusion
viral
membran
host
cell
plasma
membran
inhibit
viral
glycosyl
order
achiev
recommend
therapeut
steadi
state
plasma
whole
blood
cq
concentr
use
slow
continu
constant
iv
infus
could
recommend
sinc
could
effici
achiev
state
therapeut
concentr
control
given
low
cardiovascular
safeti
margin
cq
recommend
use
constant
iv
infus
suggest
precis
dose
infus
rate
filovir
infect
treatment
treatment
malaria
though
seemingli
reason
howev
imposs
stage
primarili
interindividu
differ
pharmacokinet
cq
absorpt
conclus
conclud
steadi
state
cq
concentr
plasma
whole
blood
respect
could
use
treatment
filovir
infect
virus
requir
acid
ph
infect
concentr
need
sustain
patient
viraemia
becom
undetect
state
concentr
howev
rule
efficaci
higher
steadi
state
concentrationsthough
concentr
might
accompani
sever
advers
effect
toxic
subsequ
research
support
conclus
preced
text
confirm
deriv
cq
protect
effect
ebola
infect
human
author
declar
conflict
interest
